Prevalence and Associated Depression Risk Factors in Patients with Chronic Obstructive Pulmonary Disease in Qazvin, Iran (2014)

Mohammadali Zohal; Leili Mohammadi; Farhad Shamloo; Amir Javadi; Zohreh Yazdi

doi:10.5152/EurJTher.2018.287

Authors

Mohammadali Zohal Department of Pulmonary Diseases, Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin https://orcid.org/0000-0002-0200-860X
Leili Mohammadi Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin https://orcid.org/0000-0002-4992-623X
Farhad Shamloo Department of Psychiatry, Qazvin University of Medical Sciences, Qazvin https://orcid.org/0000-0003-2088-124X
Amir Javadi School of Allied Sciences, Tehran University of Medical Sciences, Tehran https://orcid.org/0000-0001-7715-4583
Zohreh Yazdi Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin https://orcid.org/0000-0002-7262-5099

DOI:

https://doi.org/10.5152/EurJTher.2018.287

Keywords:

Body mass index, chronic obstructive pulmonary disease, depression, smoking

Abstract

Objective: The prevalence of depression in patients with chronic obstructive pulmonary disease (COPD) varies from country to country, and even across various geographic regions within a country. The aim of this study was to determine the prevalence of depression and its related risk factors in patients with COPD in Qazvin, Iran.

Methods: This cross-sectional study included 100 patients (34–80 years old) with COPD, referred to the pulmonary diseases clinic in Qazvin, Iran, during 2014. Demographics, medical records, current symptoms, and results of the lung function tests of the participants were recorded. Moreover, the pulmonary function was evaluated. COPD was categorized according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) system. The Beck depression inventory (BDI) was completed by all participants. Data were analyzed using the independent samples t-test, chi-squared test, and linear regression analysis.

Results: Of the 100 patients with COPD, 90 were male. The mean age was 57.57±14.06 years. Moreover, among the 100 patients with COPD, 75 had depression. 67% had symptoms of mild to moderate depression, and only 8% had severe depressive symptoms. There was a significant association between depression and independent variables of cigaret smoking (β, 0.384; p<0.05), body mass index (BMI; β, −0.383; p<0.05), and one-second forced expiratory volume (FEV1; β, −0.264; p<0.05).

Conclusion: The prevalence of depression in patients with COPD was high in this study. Smoking, BMI, and FEV1 were associated with depression. Effective interventions should be developed to address this clinical concern.

Metrics

Metrics Loading ...

References

Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 2012; 12: 53.

Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.

Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-65.

Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65-70.

Organization WH. The 10 leading causes of death in the world, 2000 and 2011. Fact sheet N. 2014;310.World Health Organization. The top 10 causes of death. Fact sheet January 2017. Available at from: http://www.who.int/mediacentre/factsheets/fs310/en/

Bhowmik K, Moniruzzaman, Adhikari A, Choudhury S, Ahmed M. Prevalence of depression and its risk factors among patients with chronic obstructive pulmonary disease in a tertiary level hospital in West Bengal, India. South East Asia Journal of Public Health 2012; 2: 34-40.

Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011; 33: 217-23.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.

World Health Organization. The global burden of disease: 2004 update. 2008. Available at from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/

Özcan A, Dursun AB, Cicek T. The comparison of anxiety and depression levels in asthma and COPD patients. World Allergy Organ J 2015; 8: A51.

Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414-9.

Ryu YJ, Chun EM, Lee JH, Chang JH. Prevalence of depression and anxiety in outpatients with chronic airway lung disease. Korean J Intern Med 2010; 25: 51-7.

Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD 2005; 2: 185-93.

Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010; 137: 341-7.

van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54: 688-92.

Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-46.

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.

Rosner RI. Beck Depression Inventory (BDI). The Encyclopedia of Clinical Psychology. 2015; 1-6.

Sarokhani D, Delpisheh A, Veisani Y, Sarokhani MT, Manesh RE, Sayehmiri K. Prevalence of Depression among University Students: A Systematic Review and Meta-Analysis Study. Depress Res Treat 2013; 2013: 373857.

Adeli S, Faker H, Mozafari A, Heidari A, Mirzapour M, Asadi M. Frequency of Depression in 207 Patients with COPD in Qom City, 2008. Qom Univ Med Sci J 2011; 5: 34-8.

Negi H, Sarkar M, Raval AD, Pandey K, Das P. Presence of depression and its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res 2014; 139: 402-8.

Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, et al. National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167: 2345-53.

De S. Prevalence of depression in stable chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2011; 53: 35-9.

Wagena EJ, Kant I, van Amelsvoort LG, Wouters EF, van Schayck CP, Swaen GM. Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking. Psychosom Med 2004; 66: 729-34.

Mineur YS, Picciotto MR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 2010; 31: 580-6.

Hayashi Y, Senjyu H, Iguchi A, Iwai S, Kanada R, Honda S, et al. Prevalence of depressive symptoms in Japanese male patients with chronic obstructive pulmonary disease. Psychiatry Clin Neurosci 2011; 65: 82-8.

Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 2009; 103: 1572-9.

Tetikkurt C, Ozdemir I, Tetikkurt S, Yılmaz N, Ertan T, Bayar N. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med 2011; 6: 226-31.

Waldron JC, Scarpa A, Lorenzi J, White SW. Depression mediates the relationship between social performance impairment and hostility. Pers Individ Dif 2015; 85: 165-71.

Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183: 604-11.